<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04759794</url>
  </required_header>
  <id_info>
    <org_study_id>3-2020-0514</org_study_id>
    <nct_id>NCT04759794</nct_id>
  </id_info>
  <brief_title>Clinical Validation of an Immunocytochemistry Method Using MARS1</brief_title>
  <acronym>MARS1</acronym>
  <official_title>Clinical Validation of an Immunocytochemistry Method Using Antibody of Methionyl-tRNA Synthetase (MARS1) in the Bile Duct Cancer Cell; Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gangnam Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gangnam Severance Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The sensitivity of brushing cytology used to distinguish the cause of biliary strictures is&#xD;
      low and clinical usefulness is not secured. The aim of this study was to validate the&#xD;
      clinical usefulness of a new differential staining method for cytology which is difficult to&#xD;
      differentiate by the conventional staining method using biliary cancer-related protein&#xD;
      expressed only in bile duct cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypothesis: The statistical significance of new staining method using aminoacyl-tRNA&#xD;
      synthetases (ARSs) group in normal bile duct cells and the bile duct cancer cells collected&#xD;
      by endoscopic retrograde pancreaticoduodenoscopy (ERCP) will be compared to prove the&#xD;
      usefulness of the new staining method.&#xD;
&#xD;
      Clinical study design: The bile duct cytology will be obtained by brushing cytology using&#xD;
      ERCP in patients with biliary stenosis. The expression of ARSs in the brushing cytology will&#xD;
      be evaluated by a new staining method and compare with the results of the conventional&#xD;
      cytology staining method including Papanicolaou staining. Immunofluorescence or&#xD;
      immunocytochemistry staining will be performed to differentiate the presence of the tumor.&#xD;
      The sensitivity and specificity of the new staining method will be compared with the&#xD;
      conventional staining method and its usefulness be confirmed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 4, 2021</start_date>
  <completion_date type="Anticipated">January 17, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 17, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>The conventional staining method and new staining method will be performed in cytology specimens obtained from the same patient.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The usefulness of new staining method</measure>
    <time_frame>1 year</time_frame>
    <description>The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of new staining method will be compared with th conventional Pap staining of brushing cytology specimens.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Bile Duct Obstruction, Extrahepatic</condition>
  <arm_group>
    <arm_group_label>Bile duct stenosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm includes patients with bile duct stenosis. Endobiliary brushing cytology specimens will be obtained with endoscopic retrograde cholangiopancreatography (ERCP) of patients with bile duct stenosis. Cytology staining will be performed in the cytology specimens.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cytology staining</intervention_name>
    <description>Two stainings will be performed in cytology specimens obtained from the same patient. The cytology specimen will be obtained through brushing cytology using endoscopic retrograde cholangiopancreatography&#xD;
conventional cytology staining method&#xD;
new cytology staining method using the antibody of aminoacyl-tRNA synthetases</description>
    <arm_group_label>Bile duct stenosis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with biliary cancer confirmed by imaging (CT, MRI, positron emission&#xD;
             tomography)&#xD;
&#xD;
          -  Patients with bile duct cancer diagnosed using brushing cytology by endoscopic&#xD;
             retrograde pancreaticoduodenoscopy&#xD;
&#xD;
          -  Patients who underwent surgical treatment with biliary cancer&#xD;
&#xD;
          -  Patients with bile duct stenosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Minors under the age of 19, vulnerable subjects such as illiteracy&#xD;
&#xD;
          -  Necrotic specimens&#xD;
&#xD;
          -  Samples with non-diagnostic cytology results and insufficient cells for further&#xD;
             evaluation&#xD;
&#xD;
          -  Samples classified as neoplastic (benign or other)&#xD;
&#xD;
          -  Patient with cholangitis in the bile duct&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sung Ill Jang, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Institutional Review Board, Gangnam Severance Hospital Yonsei University College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sung Ill Jang, MD, PhD</last_name>
    <phone>82-2-2019-3580</phone>
    <email>aerojsi88@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHA Bundang Medical Center</name>
      <address>
        <city>Seongnam</city>
        <state>Bundang-gu</state>
        <zip>13496</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chang-Il Kwon, MD., Ph.D</last_name>
      <phone>+82- 031-780-5000</phone>
      <email>endoscopy@cha.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gangnam Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Gangnam-gu</state>
        <zip>06229</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sung Ill Jang, MD., Ph.D</last_name>
      <phone>+82-2-2019-3580</phone>
      <email>aerojsi88@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>In Ha University Hospital</name>
      <address>
        <city>Incheon</city>
        <state>Jung-gu</state>
        <zip>22332</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jung Seuk, MD., Ph.D</last_name>
      <phone>+82-32-890-2548</phone>
      <email>inos@inha.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Soon Chun Hyang University Hospital, Cheonan</name>
      <address>
        <city>Cheonan</city>
        <state>Namdong-gu</state>
        <zip>31151</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tae Hoon Lee, MD., Ph.D</last_name>
      <phone>+82-041-570-2114</phone>
      <email>taewoolee9@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pusan National University Hospital</name>
      <address>
        <city>Busan-si</city>
        <state>Seo-gu</state>
        <zip>49241</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong Uk Kim, MD., Ph.D</last_name>
      <phone>+82-51-240-7472</phone>
      <email>amlm3@hanmail.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 15, 2021</study_first_submitted>
  <study_first_submitted_qc>February 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>August 11, 2021</last_update_submitted>
  <last_update_submitted_qc>August 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gangnam Severance Hospital</investigator_affiliation>
    <investigator_full_name>Sung III Jang</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>bile duct obstruction, extrahepatic</keyword>
  <keyword>cytology</keyword>
  <keyword>aminoacyl-tRNA synthetases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholestasis</mesh_term>
    <mesh_term>Cholestasis, Extrahepatic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>We plan to share the following individual participant data with other researchers during the study period.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>1 year</ipd_time_frame>
    <ipd_access_criteria>Primary investigator&#xD;
Sub primary investigator</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

